B of A Securities analyst Robert Ohmes downgrades Dollar General (NYSE:DG) from Neutral to Underperform and announces $190 price target.
Dr. Reddy’s Laboratories Announces Launch Of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial In U.S. Market
Dr. Reddy's Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's")) today announced the launch of Ephedrine Sulfate